Translational Research on Esophageal Cancer: From Cell Line to Clinic
Worldwide esophageal cancer is a signifi cant and an increasing health problem. In 2005, there were 497,700 new cases, and the prevalence is expected to increase by approximately 140% by 2025. Esophageal squamous cell carcinoma (ESCC) accounts for most of the cases of esophageal cancer worldwide (2); however, in a number of Western countries, including the Netherlands, there has been a modest decline in the incidence of ESCC and a steep rise in the frequency of esophageal adenocarcinoma (EAC).
|Publisher||Erasmus MC: University Medical Center Rotterdam|
|Promotor||Tilanus, H.W. (Hugo) , Oosterhuis, J.W. (Wolter)|
|Sponsor||The studies performed in this thesis were fi nancially supported by: The SK foundation, Stichting Erasmus Heelkundig Kankeronderzoek (SEHK) Revolving fund FC0991 Erasmus MC Rotterdam Financial support for the printing of this thesis was kindly provided by: Erasmus Universiteit Rotterdam Erasmus MC afdeling Heelkunde De Nederlandse Vereniging voor Gastroenterologie J. E. Jurriaanse Stichting|
|Keywords||esophageal cancer, gastroenterology, oncology|
Boonstra, J.J.. (2011, November 2). Translational Research on Esophageal Cancer: From Cell Line to Clinic. Erasmus MC: University Medical Center Rotterdam. Retrieved from http://hdl.handle.net/1765/26852